127 related articles for article (PubMed ID: 30570076)
1. Bloodstream infection in hematopoietic stem cell transplantation outpatients: risk factors for hospitalization and death.
Russo R; Mendes ET; Levin AS; Dulley F; Oliveira MS; Shikanai-Yasuda MA; Costa SF
Rev Inst Med Trop Sao Paulo; 2018 Dec; 61():e3. PubMed ID: 30570076
[TBL] [Abstract][Full Text] [Related]
2. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.
Mikulska M; Del Bono V; Bruzzi P; Raiola AM; Gualandi F; Van Lint MT; Bacigalupo A; Viscoli C
Infection; 2012 Jun; 40(3):271-8. PubMed ID: 22187340
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
Gjaerde LI; Moser C; Sengeløv H
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
7. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
8. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
[TBL] [Abstract][Full Text] [Related]
9. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
Puerta-Alcalde P; Chumbita M; Charry P; Castaño-Díez S; Cardozo C; Moreno-García E; Marco F; Suárez-Lledó M; Garcia-Pouton N; Morata L; Fernández-Avilés F; Martínez-Roca A; Rodríguez G; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
Transplant Cell Ther; 2021 Jun; 27(6):501.e1-501.e6. PubMed ID: 33891882
[TBL] [Abstract][Full Text] [Related]
11. The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.
Ge J; Yang T; Zhang L; Zhang X; Zhu X; Tang B; Wan X; Tong J; Song K; Yao W; Sun G; Sun Z; Liu H
BMC Infect Dis; 2018 Dec; 18(1):654. PubMed ID: 30545330
[TBL] [Abstract][Full Text] [Related]
12. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological surveillance of health care-associated infections in a pediatric hematopoietic stem cell transplantation unit in South Brazil.
Amancio L; Ihle Garcia Giamberardino H; Ferreira E; Matucheski B; Garcia Giamberardino AL
Transpl Infect Dis; 2021 Jun; 23(3):e13532. PubMed ID: 33249699
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Etiology, Risk Factors, and Outcomes of Bloodstream Infection after a Second Hematopoietic Stem Cell Transplantation.
Ohta T; Ueno T; Uehara Y; Yokoyama T; Nakazawa M; Sato Y; Uchida Y; Ohno Y; Sugio Y
Intern Med; 2023 Nov; 62(22):3305-3316. PubMed ID: 37032079
[TBL] [Abstract][Full Text] [Related]
16. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000.
Ortega M; Rovira M; Almela M; Marco F; de la Bellacasa JP; Martínez JA; Carreras E; Mensa J
Ann Hematol; 2005 Jan; 84(1):40-6. PubMed ID: 15480665
[TBL] [Abstract][Full Text] [Related]
17. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome.
Mendes ET; Dulley F; Basso M; Batista MV; Coracin F; Guimarães T; Shikanai-Yasuda MA; Levin AS; Costa SF
Int J Infect Dis; 2012 Jun; 16(6):e424-8. PubMed ID: 22463920
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.
Colombier MA; Lafaurie M; de Fontbrune FS; Resche-Rigon M; Donay JL; Pons JL; Molina JM; Socie G
Transpl Infect Dis; 2016 Aug; 18(4):504-11. PubMed ID: 27218243
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Ali N; Adil SN; Shaikh MU
Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients.
Dandoy CE; Kelley T; Gaur AH; Nagarajan R; Demmel K; Alonso PB; Guinipero T; Savelli S; Hakim H; Owings A; Myers K; Aquino V; Oldridge C; Rae ML; Schjodt K; Kilcrease T; Scurlock M; Marshburn AM; Hill M; Langevin M; Lee J; Cooksey R; Mian A; Eckles S; Ferrell J; El-Bietar J; Nelson A; Turpin B; Huang FS; Lawlor J; Esporas M; Lane A; Hord J; Billett AL
Pediatr Blood Cancer; 2019 Dec; 66(12):e27978. PubMed ID: 31486593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
